Type II Collagen
Also known as: UC-II, undenatured type II collagen, hydrolyzed type II collagen, chicken collagen type II, NK2, COL2A1
Effective Dosage
100 mg/day (undenatured form); combination products vary — No single established dose from provided studies
What the Science Says
Type II collagen is the primary structural protein in joint cartilage. It is taken as a supplement — either in its undenatured (intact) form or as hydrolyzed peptides — with the goal of reducing joint pain and improving function in conditions like knee osteoarthritis. Some clinical trials show improvements in pain scores and quality of life measures compared to placebo, particularly with undenatured chicken collagen (UC-II) taken at 100 mg/day over 6 months, but results are inconsistent across studies.
What It Doesn't Do
Doesn't reliably beat placebo in all trials — one well-run double-blind RCT found no significant difference from placebo after 12 weeks. Won't rebuild or regenerate cartilage based on current oral supplement evidence. Not a replacement for medical treatment of moderate-to-severe osteoarthritis. No evidence from provided studies that it works for healthy joints or athletic performance. Combined UC-II plus hydrolyzed collagen showed no added benefit over placebo in one trial.
Evidence-Based Benefits
Some RCTs suggest undenatured type II collagen (UC-II) may reduce pain and improve functional outcomes in knee osteoarthritis patients compared to placebo, particularly over 180-day treatment periods (PMID: 40237733, PMID: 39700461). One standardized extract (SN13108F at 100 mg/day) showed reductions in joint pain and improvements in cartilage morphology over 180 days in Kellgren-Lawrence grade II-III knee OA (PMID: 39700461). Type II collagen is also used as a biomarker of cartilage integrity (uCTX-II) in OA research rather than solely as a therapeutic agent (PMID: 40803821).
Weak EvidenceEffective at: No established dose from provided studies; trial doses ranged from 100 mg/day to combination formulas
Source: auto-research
Absorption & Bioavailability
Unknown from provided studies — absorption and mechanism of action for oral type II collagen are not directly measured in the provided papers. The undenatured form is theorized to work via oral tolerance (immune modulation) rather than direct tissue incorporation.
Red Flags to Watch For
- Most positive trials are small (32–212 patients) and some are industry-associated, raising potential bias concerns
- One independent double-blind RCT (68 patients, 12 weeks) found combined UC-II + hydrolyzed collagen performed no better than placebo
- Results are inconsistent across trials — benefit seen in some studies but not others, making it hard to predict who will respond
- Many products on the market combine multiple collagen types, making it difficult to attribute any effect to Type II collagen specifically
- Long-term safety and efficacy data beyond 6 months are not available in the provided studies
Products Containing Type II Collagen
See how Type II Collagen is used in these analyzed products:
Research Sources
- PubMed
- NIH DSLD
This information is for educational purposes only and is not medical advice. Always consult a healthcare professional before starting any supplement regimen. Last updated: 2026-04-06